(afferent limb) (8) . Efferent inhibition by syninduced "Is was shown by the fact that syninduced Ts could suppress previously sensitized recipients. Furthermore, the cotransfer of syninduced Ts and DNFB-immune TDH prevented the passive transfer of contact sensitivity into normal recipients. Inhibition of passive transfer by these Ts was shown to be both dose-dependent and antigen-specific.
In addition, we have shown that syninduced T~ were active in mediating haptenspecific suppression regardless of the recipients' genetic background (9, 10) . That is, BALB/c DNP-LC can induce T~ in BALB/c donor mice that are capable of transferring suppression to BALB/c, CBA, and C57B1/6 recipients. Similarly, these syninduced T~ of BALB/c origin were able to suppress the passive transfer of immunity by DNFB-immune BALB/c TDH or CBA TDH when cotransferred to normal recipients (8) . The induction of syninduced T~ has been shown to be restricted to combinations where the DNP-LC tolerogen and the T~ donor strain share the H-2D region of the major histocompatibility complex (MHC) (11) .
The present experiments were designed to ask what it is that T~ in the system recognize; i.e., what is their receptor(s) directed against? They were also designed to examine the possible mechanisms by which syninduced Ts exert suppression of allogeneic, DNFB-immune TOH. The results indicate that their receptor is directed against DNP-modified determinants encoded for by the MHC and that the wave of apparently non-MHC-restricted suppression is, in fact, polyclonal in nature, i.e., composed of a collection of distinct MHC-restricted T~. This is true, because the ability of T~ to suppress a particular allogeneic TDH can be specifically inhibited by absorption with DNP-membranes, MHC-compatible with the target TDH, leaving intact the ability of the T~ to suppress TDH derived from other strains.
Materials and Methods
Mice. 2-to 4-mo-old female BALB/c mice were obtained from Cumberland Farms, Clinton, Tenn. Female CBA, A/J, and C57B1/6 mice were obtained from The Jackson Laboratory, Bar Harbor, Me. A.TH mice were obtained from Dr. J. W. Moorhead, University of Colorado Medical Center, Denver, Colo.
Cell Lines. DBA/2-derived P-815 mastocytoma cells were obtained from Dr. D. W. Talmage (University of Colorado Medical Center) and maintained by serial passage in RPMI-1640 (Grand Island Biological Co., Grand Island, N. Y.) medium containing 5% fetal calf serum.
Antigens. DNFB and N-~-DNP-L-lysine HCI (DNP-lysine) were obtained from Sigma Chemical Co., St. Louis, Mo. 2,4-dinitrobenzene-l-sulfonic acid sodium salt was obtained from Eastman Kodak Co., Rochester, N. Y. Picryl sulfonic acid was obtained from Matheson, Coleman, & Bell, East Rutherford, N. J. Ovalbumin (OVA) and bovine serum albumin (BSA) were obtained from Miles Laboratories, Inc., Kankakee, II1. Mouse gamma globulin (MGG) was prepared from pooled mouse serum by ammonium sulfate precipitation.
Preparation of DNP-Proteins. BSA, OVA, and MGG were dinitrophenylated by the method of Little and Eisen (12) . The approximate molar ratios were DNP~-BSA, DNP26-OVA, and DNP15-MGG.
Preparation of Hapten-rnodified Lymphoid Cells. Erythrocyte-free spleen cell suspensions were prepared in Hanks' balanced salt solution (HBSS) and spleen cells were dinitrophenylated exactly as previously described (5) and are termed DNP-LC. Spleen cells were trinitrophenylated by incubating equal volumes of spleen cells at 20 × 106/ml in HBSS and 10 mM picryl sulfonic acid (in HBSS) for 30 min at room temperature; these are termed trinitrophenylmodified lymphoid cells (TNP-LC).
Preparation of Hapten-modified Lymphoid Cell Membranes. Membranes were prepared similar to the method of Greene, et al. (2) by subjecting DNP-LC or TNP-LC to four alternate cycles of snap freezing at -78°C in dry ice-acetone and thawing at 37°C, followed by centrifugation at 10,000 g for 45 min. The soluble membrane fragments were then dialyzed overnight against phosphate-buffered saline, pH 7.4, and adjusted to the desired number of membrane equivalents per milliliter. Membranes prepared from sham-modified cells were used as controls.
Induction of Ts.
Mice were injected i.v. with 5 × 107 syngeneie DNP-LC on day -7. On day 0, peripheral and mesenteric lymph nodes were collected and single-cell suspensions were prepared in Mishell-Dutton balanced salt solution (BSS). Control Ts consisted of lymph node cell suspensions from mice injected with sham-modified lymphoid cells (LC).
Induction of DNFB-immune TDH. DNFB-immune TDH were obtained from donors contact sensitized with 0.5% DNFB in 4:1 acetone:olive oil. Donor mice were sensitized with 25 #1 of DNFB on the shaved abdomen and 5 #1 on each ear on days 0 and 1. They also received 5 #1 on each front paw on day 1. Draining (inguinal, axillary, brachial, and cervical) lymph nodes were removed on day 4 and single-cell suspensions were prepared in BSS.
Affinity Chromatography. Cyanogen bromide-activated Sepharose 4B (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N. J.) was coupled with hyperimmune anti-H-2 d (B.10 aB10.D2) or anti-H-2 k (B.10 aB10.BR) serum. 4 × 10 s membrane equivalents of BALB/c DNP-LC membranes was applied to the columns and washed through with phosphatebuffered saline, pH 7.2. The eluate was collected and concentrated to the original volume (4.0 ml) by negative-pressure dialysis.
Blocking of
Ts. Ts to be tested were treated at a concentration of 108 cells/ml of DNP-lysine (100 ~g/ml); DNP6-BSA (500 #g/ml); DNP26-OVA (500 #g/ml); DNPIs-MGG (500 #g/ml); or DNP-LC membranes (10 s membrane equivalents/ml) for 1 h at 4°C. All DNP-congeners were diluted in BSS. Following the initial incubation, the cells were washed three times in BSS and adjusted to the proper concentration for testing their suppressive ability.
Ts Assay: Efferent Blockade. Ts were assayed for suppressive ability by testing their effect on passive transfer of contact sensitivity by immune TDH. 5 × 107 Ts (either normal or treated with DNP-congeners) were mixed with 5 × l0 T TDH and immediately transferred by i.v. injection to normal recipients syngeneic to the TDn donor. Recipients were ear challenged with 20/tl of 0.2% DNFB within 1 h of cell transfer and the degree of passive transfer was assessed 24 h later by measuring the increment in ear thickness (in units of 10 -4 in) with an engineer's dial thickness gauge. The percentage of suppression was calculated by comparing the earswelling response of mice receiving both TDH and Ts (experimental) with those receiving TDH and sham "Is (positive controls), and negative (ear challenged only) control mice: percentage of suppression = [(Positive control -experimental)/(positive control -negative control)] × 100%.
Results
Rationale. The experiments were designed to ask what it is that mature Ts recognize by determining their ability to be blocked by various DNP-congeners (Fig. 1) . To accomplish this, T~ were treated in suspension with the various DNP-congeners, washed, and 5 × 107 cells were cotransferred to normal, syngeneic recipients along with 5 × 107 TDH. Recipients were ear challenged within 1 h of transfer and the degree of passive transfer determined 24 h later by measuring ear-swelling responses. Lack of ear swelling in the recipient mouse indicates suppression by active Ts. In contrast, a positive ear-swelling response in the recipient mouse indicates that Ts were blocked by the preincubation and are thus incapable of inhibiting the expression of CMI by the transferred TDH cells. It should be pointed out that concentrations of DNP26-OVA up to 2.0 mg/ml had no effect on T~ activity, and that concentrations of DNP-lysine >100/~g/ml were toxic.
Hapten and MHC Specificity of LC-membrane preparations. After washing, 5 × 10 7 treated Ts were mixed with 5 X 10 7 Ton and transferred to BALB/c recipients. The results (Fig. 3) show that T8 treated with sham-modified BALB/c LC membranes suppress passive transfer 83.8% (group B), and pretreatment with DNP-modified BALB/c LC membranes reversed this to 5.1% suppression (group C). Treatment of the DNP-specific T~ with TNPmodified BALB/c LC membranes had no significant effect on their suppressive ability as they reduced passive transfer by 78.2% (group D). Thus, the Ts receptor is exquisitely hapten-specific. Neither sham-(group E) nor DNP-modified (group F) CBA LC membrane preparations significantly reduced the suppressive ability of BALB/c T~ on BALB/c Ton. Thus, blocking of syngeneic suppression requires that DNP be present on syngeneic membrane determinants. We have also tested the ability of syngeneic and allogeneic DNP-membrane preparations to directly block DNFBimmune Tori and have found that both are effective blockers (Stephen D. Miller, data not shown). This observation may indicate a basic difference in the antigen recognition system used by T8 as opposed to Ton. were prepared and applied to anti-H-2 d or anti-H-2 k affinity columns. The materials not adherent to the columns were collected, concentrated, and tested for their ability to block BALB/c syninduced Ts (Fig. 4) . 5 × 107 untreated BALB/c T8 suppressed the passive transfer by 5 × 107 BALB/c TDH by 87.2% (group B). Treatment of Ts with the material recovered after passage of BALB/c DNP-LC membranes over an irrelevant anti-H-2 k column reversed this suppression to an insignificant 4.0% (group C). However, removal of DNP-modified BALB/c MHC-encoded determinants on a specific anti-H-2 d column rendered the membranes unable to block the T, (group D, 75.6%). Thus, T8 recognize DNP-modified, syngeneic MHC-encoded determinants in a syngeneic suppression system.
Ts Recognition lnvolves Hapten-rnodified MHC-encoded

Requirement for H-2D-Region Compatibility for Blocking of Syngeneic Suppression by Syninduced T~.
Experiments were done to define the DNP-modified MHC-encoded membrane determinants responsible for blocking the suppressive action of syninduced T~. Initial experiments examined the blocking effects of A/J DNP-LC membranes on BALB/c and CBA syninduced T~ ( (Fig. 6) . As shown previously, untreated BALB/c T~ suppressed the TDH response by 91.8% (group B), and pretreatment with syngeneic BALB/c DNP-LC membranes reversed suppression to a level of 6.2% (group C). Pretreatment with DNP-modified P-815 membranes (H-2K-and H-2D-region compatible) or with A.TH DNP-LC membranes (H-2D-region-only compatible) also reversed the suppressive ability of BALB/c T~ (groups D and E). These data indicate that T~ recognize DNP-H-2D-region determinants, as H-2D-region compatibility between syninduced T~ and the DNP-LC membrane preparation is required for blocking of suppression.
Allosuppression by Syninduced Ts is Not Blocked by Pretreatment with DNP-LC Membranes
Syngeneic to the T~. The data to this point clearly show that pretreatment of syninduced T~ with DNP-LC membranes compatible at the H-2D region block the ability of the T~ to suppress syngeneic TDH. AS we have previously shown that syninduced Ts are not genetically restricted and will suppress allogeneic TDH upon cotransfer (8) , it was of interest to examine the membrane requirements for blocking of their allosuppressive ability. Two experiments in this regard are shown in Fig. 7 . In experiment , but they still retained their allosuppressive ability for CBA TDH (group E). BALB/c T, pretreated with allogeneic DNP-modified CBA LC membranes could still suppress syngeneic BALB/c TDH (group C and Fig. 3 ), but were no longer able to suppress allogeneic CBA TDH (group F). In experiment two, BALB/c T~ pretreated with CBA DNP-LC membranes were tested for their ability to suppress passive transfer of sensitivity by BALB/c, CBA, and C57B1/6 TDH. As expected, untreated BALB/c T~ suppressed passive transfer mediated by TDH of each haplotype (groups G, I, and K). Those T~ pretreated with CBA DNP-LC membranes suppressed BALB/c (group H) and third-party C57B1/6 (group L) TDH, but could no longer suppress CBA TDn (group J). These data indicate that the allosuppressive ability of syninduced Ts is not blocked by treatment with DNP-LC membranes syngeneic to the Ts, but allosuppression is blocked by pretreatment of the T~ with DNP-LC membranes syngeneic to the TDH donor. Thus, it appears that i.v. injection of DNP-modified syngeneic LC leads to a polyclonal wave of T~, separate members of which can suppress the response of TD~ from various haplotypes. Allosuppression can be blocked by pretreatment of the T~ with DNP-LC membranes syngeneic to the immune TDH in question, but this treatment has no effect on the ability of the T~ to suppress TDn derived from the same strain as the Ts or third-party-derived TDH.
Allosuppression by Syninduced T~ Involves Recognition of Allogeneic DNP-modified H-2D-End Determinants.
Experiments were done next to determine the nature of the determinants involved in blocking the allosuppressive function of syninduced T,. A/J DNP-LC membranes were used to treat either CBA or BALB/c syninduced T~. The allosuppressive ability of these T~ was then tested. The results (Fig. 8) show that CBA syninduced Ts suppress BALB/c TDn by 99% (group B) and that pretreatment of those Ts with A/J DNP-LC membranes reverses their allosuppressive ability to only 5.7% (group C). Thus, pretreatment of T~ with DNP-LC membranes compatible at the IC ~ D regions of the MHC with the allogeneic target TDn is sufficient for blockade of allosuppression. In the converse experiment, it can be seen that BALB/c syninduced Ts suppress passive transfer of CMI by CBA TDn by 80.1% (group E); however, pretreatment with A/J DNP-LC membranes has no effect on their allosuppressive action (group F, 94.0%). It should be restated that A/J DNP-LC membranes are sufficient for blocking the suppressive ability of BALB/c T~ on syngeneic BALB/c TDH (Fig. 5, group C) . Thus, pretreatment of syninduced Ts with DNP-LC membranes compatible at the K --* IE loci of the MHC with the target TDn is not sufficient for blockage of allosuppression. Therefore, allosuppression, like syngeneic suppression, is directed against DNP-modified H-2D-end determinants.
Relative Affinity of Syninduced T8 for DNP-modified Syngeneic and Allogeneic Determinants. It was of interest to determine the relative affinities of blocking of Ts
by syngeneic DNP-LC membranes on suppression of syngeneic TDH, and blocking by allogeneic DNP-LC membranes on aUosuppression by Ts. To accomplish this, BALB/c syninduced Ts were treated with varying concentrations of either BALB/c or CBA DNP-LC membranes, washed, and then tested for their suppressive action on both BALB/c and CBA TDH (Fig. 9) . In terms of syngeneic suppression, BALB/c Ts treated with l0 s BALB/c DNP-LC membrane equivalents reversed their suppressive ability from 90.6% (group B) to only 15.1% (group C). Dilutions of 107 and 106 DNP-LC membrane equivalents were much less effective in blocking suppression, yielding 46.9% (group D) and 84.7% (group E) suppression, respectively. Thus, at least 108 DNP-membrane equivalents are required to reverse suppression of syngeneic TDn. In contrast, treatment of these same Ts with from 108 to l0 s CBA DNP-LC membrane equivalents was sufficient to reverse their allosuppressive action on CBA Ton from 96.9% (group (3) to insignificant levels (groups H-J). These data indicate that the receptor on the clone(s) of T~ able to recognize DNP-modified allogeneic determinants is of much higher affinity than is receptor recognition of DNP-modified syngeneic determinants (toward which the Ts population was generated). Discussion This report has examined the nature of the suppressive interaction of DNP-specific syninduced Ts (induced by the i.v. injection of syngeneic DNP-LC) on the passive transfer of DNFB contact sensitivity by syngeneic and allogeneic immune TDH. The restdts show that the syngeneic suppressive function of T8 is effectively blocked only when the Ts are pretreated with syngeneic, soluble DNP-LC membrane preparations, not by monomeric DNP-lysine or polyvalent DNP-protein conjugates. The blocking by hapten-modified membranes is also hapten-specific as TNP-modified syngeneic membranes do not block DNP-specific Ts. In terms of MHC requirements for blocking the suppressive action of Ts on syngeneic TDH, it was found that DNP-LC membranes which shared only the H-2D region with the Ts were sufficient and necessary for inhibiting T~ function, a restriction we had earlier reported for the induction of syninduced T~ by DNP-LC (11). The failure of DNP-lysine, DNP-protein, and DNP-allogeneic membrane to block suppression of syngeneic TDn by Ts is a strong indication that the MHC-unrcstricted nature of the T~ cannot be explained by the fact that the T~ recognize only hapten. Ts apparently recognize DNP in association with the correct membrane determinant, i.e., DNP-H-2D. The fact that the T~ receptor is directed against hapten-modified MHC-encoded determinants is somewhat at odds with earlier studies concerning carrier-specific suppression in antibody systems. Okumura et al. (13) have reported that keyhole limpet hemocyanin (KLH)-specific T~ could be bound to an antigen immunoabsorbant column and therefore were enriched by this procedure. Interestingly, they also showed that KLH-specific helper T cells, run under identical conditions, were not retained on these columns. More recently, Taniguchi and Miller (14) reported that human gamma globulin-specific T~ could be enriched by adherence to antigen-coated Petri dishes. The current observations indicate that DNP-specific Ts see antigen in the context of MHC gene products. A trivial explanation of these observations could be that the affinity of binding of T8 to multideterminant antigencoated beads or Petri dishes may be sufficient for their retention, whereas, our attempts to inhibit Ts function in cell suspensions by treatment with DNP-lysine or DNP-proteins did not provide a sufficiently stable binding for functional inhibition. A more likely possibility is that the real antigen formed in contact sensitivity to DNFB is a DNP-conjugated, self-membrane component. As Ts are also raised by immunization with DNP-syngeneic membranes, it is likely that they recognize, and are blocked by, DNP-membrane components and not by DNP on lysine, serum protein, or allogeneic membrane. Indeed, the fact that syngeneic DNP-membrane preparations were avid blockers of T~ function (in suspension) reflects this type of receptor specificity of the T~. It should also be noted that the phenotype of DNP-specific syninduced T, is Thy 1 + (7), Lyl-2+3 +, I-J + (S. D. Miller, unpublished data) similar to the T~ in the above-mentioned, carrier-specific T~ systems. Thus, differences due to a phenotypically different effector T~ in the systems does not appear likely.
We also investigated the mechanisms of allosuppression by syninduced "Is, because we have previously reported that syninduced T, are not genetically restricted and will suppress DNP-specific, allogeneic TDH upon cotransfer into the appropriate allogeneic recipient (8) . The data reported here show that although pretreatrqent of syninduced T~ with syngeneic DNP-LC membranes will block their suppressive action on syngeneic TDH, these T~ are still fully capable of suppressing allogeneic TDn. This result again indicates that it is unlikely that allosuppression is directed toward hapten alone or directed against DNP-modified, public MHC determinants. That the allosuppressive action of syninduced T~ is specific was shown by the fact that suppression directed against a specific allogeneic Ton could be inhibited only by pretreatment of the T, with DNP-LC membranes that were H-2D-end compatible with the target allogeneic TDH cells. Therefore, allosuppression appears to be specifically directed against the DNP-modified allogeneic H-2D-end determinants.
It appears that, after perturbation of the immune system by i.v. injected, DNPmodified, syngeneic LC, a polyclonal wave of T~ is invoked. Some members of this set recognize DNP-modified syngeneic determinants with high affinity and syngeneic suppression can thus be inhibited by pretreatment of the T~ with those DNP determinants. Other members of this set, once induced, display receptors directed against DNP-modified allogeneic determinants and thus suppress the passive transfer of CMI by allogeneic TDH. These allosuppressive clones can be specifically inhibited by pretreatment with the correct allogeneic DNP-modified MHC-encoded determinants, without inhibiting the ability of the T~ population to suppress syngeneic or third-party Ton. T cells with receptors for autologous MHC products associated with antigen (hapten or virus) have been shown to cross-react extensively. The elegant experiments of Lemonnier et al. (15) and Burakoff et al. (16) , using cytotoxic T cells, illustrate this point. They showed that cytotoxic T cells generated against allogeneic determinants can specifically lyse autologous cells coupled with TNP molecules (15) . More recent work has shown that cytotoxic T cells stimulated by Sendai virusmodified syngeneic cells can lyse both syngeneic virus-coated targets as well as noninfected allogeneic cells (16) . Thus, it is not unlikely that a set of Ts stimulated in viva by DNP-modified syngeneic cells would be able to recognize both DNP-modified syngeneic and DNP-modified allogeneic determinants.
The data can also be explained according to a dual receptor hypothesis of T-cellantigen recognition similar to that advanced by Janeway et al. (17) and to a similar hypothesis outlined by Doherty et al. (18) . We have previously invoked this model several years ago to interpret our results (10) . According to this model, the i.v. injection of DNP-BALB/c LC into BALB/c mice activates a library of pre-T8 clones, perhaps independent of macrophage presentation (19, 20) , each with low-to-moderate affinity receptors for DNP-BALB/c self-determinants. These clones ar~ designated Ts-A, Ts-B, and T~-C, for example (Fig. 10) . Each has receptor No. 1 directed to DNP and VH products in receptor No. 2 that recognize self (BALB/c) either with moderate affÉnity (T~-A) or with low affinity (Ts-B, T~-C, etc.). The aggregate of all these T~ with affinity for BALB and DNP, or perhaps only those with moderate affinity for BALB and a receptor for DNP, is sufficient to suppress syngeneic BALB/c TDn. However, one of these clones has a receptor No. 2 that fortuitously cross-reacts with the CBA MHC with high affinity (Ts-B). The activation of this clone by i.v. injected BALB/c membrane will thus generate what might be called a heteroclitic T~ which is efficient in suppressing CBA-immune TDH.
In the blocking experiments, it is postulated that only "Is with an affinity for an MHC of moderate strength will be blocked by DNP-membranes, at least under the conditions used in these experiments. Thus, DNP modified-BALB/c LC membranes will block Ts-A and inhibit the ability of the syninduced T8 to suppress BALB/c TDn. However, as T~-B and T~-C have only low affinity for BALB/c, the ability of these T~ within the aggregate of syninduced Ts to block CBA TDn (Ts-B) and C57B1/6 TDn (Ts-C) is unimpaired. Treatment of the T~ population with CBA DNP-LC membranes would inhibit only clone T~-B (with a high-affinity receptor for DNP-CBA) and leave intact the ability of the Ts-A clone to suppress BALB/c TDn. This would explain the genetic restrictions of blocking of syngeneic suppression. In terms of allosuppression, pretreatment of BALB/c syninduced T~ with syngeneic BALB/c DNP-LC membranes would efficiently block only those clones with moderate affinity for self (T~-A), but may not efficiently block clone T,-B (with low affinity for self, but high affinity for DNP-H-2 k) or T~-C (high affinity for DNP-H-2b); thus, T8 could still suppress CBA and C57Bl/6 Tnn. As explained above, pretreatment of BALB/c syninduced T~ with CBA DNP-LC membranes would only block those clones with high-affinity receptors for DNP-H-2 k (Ts-B), leaving the suppressive activity for self (by the aggregate of moderate-affinity T~-A) and for third party TDH (e.g., clones [T~-C] that would crossreact with DNP-C57B1/6 (H-2 b) determinants with high affinity). A prediction of this model would be that allosuppressive clones would be fewer in number and/or have higher-affinity receptors for allogeneic DNP determinants. The results presented in Fig. 9 , that show that blocking of suppression of syngeneic TDH requires greater concentrations of DNP-LC membranes than blocking of suppression of allogeneic TDn, would seem to support this hypothesis.
The mechanism of efferent limb blockade by syninduced T~ is not clear at this time. T~ may act by competing for the immunogenic form of DNP-self presented by stimulator macrophages at the each challenge site. Alternatively, T~ may act on the immune TDH cell by direct contact or via a soluble suppressor factor mechanism (21, 22) . In terms of the latter possibility, it has been shown (J. W. Moorhead, unpublished data) that TDH in this system bear surface DNP associated with H-2K and H-2D determinants. One could envision the recognition of this DNP-H-2D, Ton surface complex by Ts that either directly inactivate the TDH or liberate an antigen-specific suppressor factor. Experiments to define the exact locus of suppression by syninduced T8 are currently in progress.
Summary
This report has examined the mechanisms by which major histocompatibility complex (MHC) non-restricted suppressor T cells (Ts), induced by the i.v. injection of 2,4-dinitrophenyl (DNP)-modified, syngeneic lymphoid cells (DNP-LC), suppress the passive transfer of contact sensitivity mediated by syngeneic and allogeneic immune delayed hypersensitivity T cells (TDH). In terms of suppression of syngeneic TDH, it was found that the suppressive action of the Ts was only blocked by pretreatment with soluble syngeneic DNP-LC membrane preparations. Monomeric DNP-lysine, polymeric DNP-protein conjugates, and syngeneic TNP-LC membranes did not inhibit Ts function. Further experiments showed that inhibition of syngeneic suppression could be achieved by DNP-modified-membrane preparations that were only H-2D-region compatible with the T~ donor. Thus, T~ antigen receptors in this system specifically recognize DNP-modified H-2D-region determinants.
In contrast, it was found that pretreatment of syninduced Ts with syngeneic DNP-LC membranes did not inhibit the ability to suppress allogeneic TDI~. However, pretreatment of Ts with DNP-allogeneic membranes which were H-2D-end compatible to the allogeneic target TDH eliminated their ability to suppress the specific allogeneic TDH, leaving intact suppression of syngeneic or third party TDH. It is proposed that perturbation of the immune system by i.v. injection of syngeneic DNP-LC leads to the induction of a polyclonal wave of DNP-specific Ts activity. Some members of this set of T, recognize DNP-self MHC determinants with moderate affinity and are thus specifically inhibited after pretreatment with those DNP-self determinants. Other members of this set display receptors which cross-react with high affinity with DNP-allogeneic determinants and thus suppress allogeneic TDH cells. These allosuppressive clones can thus be specifically inhibited only by pretreatment with DNP-LC membranes, MHC-compatible with the target TDI~. The data are discussed in terms of current models of T-cell cross-reactivity and T-cell-receptor recognition.
